| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.THROMRES.2009.10.006 |
| P698 | PubMed publication ID | 19939440 |
| P50 | author | Fariborz Mobarrez | Q43235582 |
| Håkan Wallén | Q61895694 | ||
| P2093 | author name string | Kjell Hultenby | |
| Gun Jörneskog | |||
| Nils Egberg | |||
| Jovan Antovic | |||
| Mona Hansson | |||
| P433 | issue | 3 | |
| P921 | main subject | flow cytometry | Q1141429 |
| P304 | page(s) | e110-6 | |
| P577 | publication date | 2009-11-24 | |
| P1433 | published in | Thrombosis Research | Q15758741 |
| P1476 | title | A multicolor flow cytometric assay for measurement of platelet-derived microparticles | |
| P478 | volume | 125 |
| Q37563984 | A flow cytometric method for characterization of circulating cell-derived microparticles in plasma |
| Q92741776 | Acute effects of haemodialysis on circulating microparticles |
| Q36214925 | Alternative methods for characterization of extracellular vesicles. |
| Q52840093 | Analysis of platelet-derived extracellular vesicles in plateletpheresis concentrates: a multicenter study. |
| Q26771759 | Antibody-Based Assays for Phenotyping of Extracellular Vesicles |
| Q39159683 | Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome |
| Q90045050 | Biological surface properties in extracellular vesicles and their effect on cargo proteins |
| Q43641406 | CD40L expression in plasma of volunteers following LPS administration: A comparison between assay of CD40L on platelet microvesicles and soluble CD40L. |
| Q33729477 | Cellular sources of tissue factor in endotoxemia and sepsis |
| Q98394686 | Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology |
| Q38944216 | Circulating cell-derived microparticles as biomarkers in cardiovascular disease |
| Q44814556 | Effect of lipopolysaccharide administration on the number, phenotype and content of nuclear molecules in blood microparticles of normal human subjects. |
| Q52915225 | Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease. |
| Q44284893 | Evaluation of microparticles in whole blood by multicolour flow cytometry assay |
| Q56358143 | Extracellular Vesicles: A Novel Target for Exercise-Mediated Reductions in Type 2 Diabetes and Cardiovascular Disease Risk |
| Q36217912 | Flow Cytometry as a Tool for Quality Control of Fluorescent Conjugates Used in Immunoassays |
| Q35688330 | High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes |
| Q59328863 | Impact of preanalytical conditions on plasma concentration and size distribution of extracellular vesicles using Nanoparticle Tracking Analysis |
| Q48298103 | In vitro properties of concentrated canine platelets stored in two additive solutions: a comparative study |
| Q45807873 | Is a decrease of microparticles related to improvement of hemostasis after FVIII injection in hemophilia A patients treated on demand? |
| Q41390164 | Leukocyte-derived microparticles and scanning electron microscopic structures in two fractions of fresh cerebrospinal fluid in amyotrophic lateral sclerosis: a case report |
| Q38647460 | Measurement of microvesicle levels in human blood using flow cytometry |
| Q38364069 | Microparticle analysis in disorders of hemostasis and thrombosis |
| Q27016054 | Microparticles as mediators and biomarkers of rheumatic disease |
| Q38823104 | Microparticles in sickle cell anaemia: promise and pitfalls |
| Q37770410 | Microparticles in stored red blood cells: submicron clotting bombs? |
| Q37363894 | Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations |
| Q37032283 | Microparticles variability in fresh frozen plasma: preparation protocol and storage time effects. |
| Q37837956 | Microparticles, malignancy and thrombosis |
| Q36745194 | Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets |
| Q49807920 | Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases |
| Q57574568 | Microvesicles from platelets: novel drivers of vascular inflammation |
| Q57785942 | Miniaturized Biomedical Sensors for Enumeration of Extracellular Vesicles |
| Q51493562 | Non-contact acoustic capture of microparticles from small plasma volumes. |
| Q53063504 | Oat-enriched diet reduces inflammatory status assessed by circulating cell-derived microparticle concentrations in type 2 diabetes. |
| Q55522882 | Oxygen-Related Differences in Cellular and Vesicular Phenotypes Observed for Ovarian Cell Cancer Lines. |
| Q94600467 | Phosphatidylserine positive microparticles improve hemostasis in in-vitro hemophilia A plasma models |
| Q64967555 | Plasma microparticles are not elevated in fresh plasma from patients with gynaecological malignancy--an observational study. |
| Q26823775 | Platelet function tests: a review of progresses in clinical application |
| Q42593174 | Platelet storage media change the expression characteristics of the platelet-derived microparticles |
| Q63488621 | Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status |
| Q37824743 | Platelet-derived microparticles - an updated perspective |
| Q35738647 | Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. |
| Q50793092 | Studies of microparticles in patients with the antiphospholipid syndrome (APS). |
| Q41923180 | T lymphocytes export proteasomes by way of microparticles: a possible mechanism for generation of extracellular proteasomes |
| Q35460716 | Techniques for the analysis of extracellular vesicles using flow cytometry |
| Q41969213 | Techniques to improve detection and analysis of extracellular vesicles using flow cytometry |
| Q38634490 | The diagnostic usefulness of capture assays for measuring global/specific extracellular micro-particles in plasma |
| Q35108949 | The effects of smoking on levels of endothelial progenitor cells and microparticles in the blood of healthy volunteers |
| Q52926108 | The expression of microvesicles in the blood of patients with Graves' disease and its relationship to treatment. |
| Q38106745 | The role of microparticles in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus |
| Q37288296 | Tissue factor structure and function |
| Q41553743 | Tissue factor/factor VIIa signalling promotes cytokine-induced beta cell death and impairs glucose-stimulated insulin secretion from human pancreatic islets |
| Q35881752 | Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques. |
Search more.